£33.2m to protect public from future epidemics and pandemics

• Eight new vaccine projects will receive £33.2m funding to develop treatments against high-threat pathogens, enhancing the UK's pandemic preparedness capabilities
• Funding focuses on diseases with epidemic and pandemic potential, aiming to reduce global health risks and support international disease prevention efforts
• Investment strengthens the UK's position in vaccine development while contributing to worldwide protection against future infectious disease outbreaks

£33.2m will fund eight vaccine projects targeting deadly diseases, strengthening UK pandemic preparedness and helping protect people worldwide.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.